<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00892606</url>
  </required_header>
  <id_info>
    <org_study_id>UofL IRB # 08.0200</org_study_id>
    <nct_id>NCT00892606</nct_id>
  </id_info>
  <brief_title>Methadone Versus Morphine for Orthopedic Surgery Patients</brief_title>
  <official_title>Effectiveness of Pre-Operative Methadone Versus Morphine for Post-Operative Analgesia in Orthopedic Surgery Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Louisville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Louisville</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators propose to compare analgesia by methadone and ketamine with a combination
      of morphine and ketamine in orthopedic surgery patients with moderate to severe pain. The
      investigators hypothesize that when given with ketamine before surgical incision, methadone
      is more effective than morphine in reducing postoperative morphine consumption and reducing
      pain during movement.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will receive 1-4 mg midazolam before being transferred to the operating room. All
      patients will receive standard ASA monitoring. In the operating room, the anesthesiologist
      will open a randomization envelope to determine patient group assignment (see below).
      Patients will be anesthetized with 0.2 mg/kg ketamine, 2 µg/kg fentanyl and propofol or
      etomidate IV. Muscle relaxant of the anesthesiologist's choice will be given and the patient
      will be intubated. After intubation, the computer-generated randomization codes stored in
      opaque envelopes will be opened. The patients will be randomized to one of two groups:

        1. Methadone group: Patients will receive 0.2 mg/kg of methadone IV immediately after
           intubation

        2. Control group: Patients will receive 0.2 mg/kg of morphine IV immediately after
           intubation

      The unblinded investigator will draw the drug and dilute to a total volume of 10 cc. This
      syringe will be handed to the anesthesia provider, who will administer the medication after
      induction. They will be maintained with oxygen, air and an inhalational agent of
      anesthesiologist's choice, targeted at BIS between 40 and 60. Additional analgesia will be
      provided with fentanyl in 50 µg increments as required throughout surgery. At the end of
      surgery the neuromuscular block will be reversed and patients will breathe spontaneously.
      Fentanyl will be titrated to maintain a respiratory rate of 12-15 breaths per minute to
      obtain an O2 saturation &gt; 95% and the other extubation criteria are met before tracheal
      extubation . The intraoperative use of narcotics, sedatives and anesthetic drugs will be
      noted. The type of surgery, the duration of surgery and use of additional analgesics and
      antiemetics will be noted.

      An investigator blinded to randomization will track the patients in the PACU. If rescue
      medication is necessary, morphine IV will be given in 2-4 mg increments up to a total of 20
      mg. If the patients continue to report pain (VAS &gt; 4), IV hydromorphone will be given in 0.5
      mg dose every 10-15 minutes until the patient has adequate analgesia (VAS &lt; 4), as decided by
      the PACU nurse.

      Patients will receive morphine patient-controlled analgesia (PCA) for pain relief as the
      primary analgesic. Percocet (Acetaminophen/Oxycodone 325 mg/5 mg) or Lortab
      (Acetaminophen/Hydrocodone 325/5 mg) will be prescribed as needed to maintain VRS &lt; 4.

      In the PACU, vital signs including respiratory rate, heart rate, non-invasive blood pressure,
      sedation score and oxygen saturation will be recorded every 15 minutes. VAS scores for pain
      will be obtained from the patient every 15 minutes until the patient is discharged to the
      floor. VAS (visual analog scale) is a 100-mm scale where 0 = no pain and 100 = worst pain
      imaginable. The investigator will record sedation scores every 15 minutes using the following
      scale until patient is discharged to the floor:

      0-Patient is fully alert

        1. Patient has intermittent sedation

        2. Patient sedated but responsive to verbal stimuli

        3. Patient unresponsive to verbal stimuli

      Patients will be seen at 8 am and 4 pm on the following day and will be contacted at home or
      in the hospital on POD 2 and 3 for information regarding pain scores and analgesic
      requirement. The initial dose of rescue analgesic and time it is given will be recorded. VAS
      at rest and on movement will be recorded, when the patients are seen or VRS will be recorded
      via phone contact. Morphine or other analgesics required during the first 24 and 48 hours
      after surgery, and times to first ambulation, first fluid, solid and flatus will be recorded,
      as will incidence and severity of postoperative nausea and vomiting be recorded.

      Our primary outcome will be opioid consumption during the 48 hours after surgery. All
      analgesics consumed will be converted to morphine equivalent.

      The secondary outcomes will be

        1. Overall rescue analgesic, converted into equipotent doses compared between the two
           groups

        2. Side effects with special attention paid to respiratory rate and possible respiratory
           depression, and PONV

        3. Visual pain score at 48 h post-op.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid Consumption During the 48 Hours After Surgery</measure>
    <time_frame>48 hours</time_frame>
    <description>The amount of opioid required for postoperative pain relief</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Post Operative Nausea and Vomiting</measure>
    <time_frame>48 hours</time_frame>
    <description>rates subjects experienced PONV</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Pain Score</measure>
    <time_frame>48 hours</time_frame>
    <description>Patients rated their pain with the numerical VPS from 0 to 10, with 10 being the worst pain possible and 0 being no pain</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Fracture</condition>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Methadone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients received 2 µg/kg fentanyl, 0.2 mg/kg ketamine and 0.2 mg/kg of methadone IV with induction of general anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients received 2 µg/kg fentanyl, 0.2 mg/kg ketamine, and 0.2 mg/kg morphine (standard of care)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methadone</intervention_name>
    <description>Patients will receive 0.2 mg/kg of methadone IV immediately after intubation</description>
    <arm_group_label>Methadone</arm_group_label>
    <other_name>Symoron</other_name>
    <other_name>Dolophine</other_name>
    <other_name>Amidone</other_name>
    <other_name>Methadose</other_name>
    <other_name>Physeptone</other_name>
    <other_name>Heptadon</other_name>
    <other_name>6-(Dimethylamino)-4,4-diphenylheptan-3-one (IUPAC name)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>Patients will receive 0.2 mg/kg of morphine IV immediately after intubation</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>Opiate</other_name>
    <other_name>(5α,6α)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I-III

          -  Ages 18-65 years

          -  Presenting for lower extremity orthopedic surgery involving fracture of long bones at
             University of Louisville Hospital

          -  Surgery expected to last more than one hour

          -  Patient expected to have moderate to severe post-operative pain

          -  Patient refused regional anesthesia or has a contraindication to regional anesthesia

        Exclusion Criteria:

          -  Any known contraindications to methadone including hypothyroidism, Addison's disease,
             prostatic hypertrophy, or urethral stricture.

          -  Difficulty or inability to understand the study or protocol

          -  Known renal or hepatic dysfunction

          -  BMI&gt; 35

          -  Known respiratory or cardiovascular problems, such as obstructive sleep apnea or
             oxygen saturation of less than 92% on room air

          -  Taking any of the known drugs that induce or inhibit the cytochrome p450 enzyme
             systems. Common examples of these drugs are antifungal, antiretroviral, barbiturates,
             dexamethasone, and macrolide antibiotics.

          -  Pregnancy

          -  Taking preoperative opioids for more than 2 weeks before the surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anupama Wadhwa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Louisville</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Louisville Hospital</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Wadhwa A, Clarke D, Goodchild CS, Young D. Large-dose oral dextromethorphan as an adjunct to patient-controlled analgesia with morphine after knee surgery. Anesth Analg. 2001 Feb;92(2):448-54.</citation>
    <PMID>11159249</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 30, 2009</study_first_submitted>
  <study_first_submitted_qc>May 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 4, 2009</study_first_posted>
  <results_first_submitted>April 6, 2017</results_first_submitted>
  <results_first_submitted_qc>April 6, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">May 17, 2017</results_first_posted>
  <last_update_submitted>May 16, 2017</last_update_submitted>
  <last_update_submitted_qc>May 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Surgery, Orthopedic</keyword>
  <keyword>Pain, Postoperative</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Methadone</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Methadone</title>
          <description>Patients will receive 0.2 mg/kg of methadone IV immediately after intubation
Methadone: Patients will receive 0.2 mg/kg of methadone IV immediately after intubation</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>Patient will receive current standard-of-care: 0.2 mg/kg of morphine IV immediately after intubation
Morphine: Patients will receive 0.2 mg/kg of morphine IV immediately after intubation</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="38"/>
                <participants group_id="P2" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Methadone</title>
          <description>Patients received 2 µg/kg fentanyl, 0.2 mg/kg ketamine, and 0.2 mg/kg of methadone IV immediately after intubation</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>Patients received 2 µg/kg fentanyl, 0.2 mg/kg ketamine, and 0.2 mg/kg morphine</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="38"/>
            <count group_id="B2" value="37"/>
            <count group_id="B3" value="75"/>
          </count_list>
        </analyzed>
        <analyzed>
          <units>participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="38"/>
            <count group_id="B2" value="37"/>
            <count group_id="B3" value="75"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37" spread="13"/>
                    <measurement group_id="B2" value="35" spread="12"/>
                    <measurement group_id="B3" value="36" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <units_analyzed>Participants</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Opioid Consumption During the 48 Hours After Surgery</title>
        <description>The amount of opioid required for postoperative pain relief</description>
        <time_frame>48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Methadone</title>
            <description>Patients will receive 0.2 mg/kg of methadone IV immediately after intubation
Methadone: Patients will receive 0.2 mg/kg of methadone IV immediately after intubation</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patient will receive current standard-of-care: 0.2 mg/kg of morphine IV immediately after intubation
Morphine: Patients will receive 0.2 mg/kg of morphine IV immediately after intubation</description>
          </group>
        </group_list>
        <measure>
          <title>Opioid Consumption During the 48 Hours After Surgery</title>
          <description>The amount of opioid required for postoperative pain relief</description>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51" spread="19"/>
                    <measurement group_id="O2" value="87" spread="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0072</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Post Operative Nausea and Vomiting</title>
        <description>rates subjects experienced PONV</description>
        <time_frame>48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Methadone</title>
            <description>Patients will receive 0.2 mg/kg of methadone IV immediately after intubation
Methadone: Patients will receive 0.2 mg/kg of methadone IV immediately after intubation</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patient will receive current standard-of-care: 0.2 mg/kg of morphine IV immediately after intubation
Morphine: Patients will receive 0.2 mg/kg of morphine IV immediately after intubation</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Post Operative Nausea and Vomiting</title>
          <description>rates subjects experienced PONV</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.004</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visual Pain Score</title>
        <description>Patients rated their pain with the numerical VPS from 0 to 10, with 10 being the worst pain possible and 0 being no pain</description>
        <time_frame>48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Methadone</title>
            <description>Patients will receive 0.2 mg/kg of methadone IV immediately after intubation
Methadone: Patients will receive 0.2 mg/kg of methadone IV immediately after intubation</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patient will receive current standard-of-care: 0.2 mg/kg of morphine IV immediately after intubation
Morphine: Patients will receive 0.2 mg/kg of morphine IV immediately after intubation</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Pain Score</title>
          <description>Patients rated their pain with the numerical VPS from 0 to 10, with 10 being the worst pain possible and 0 being no pain</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" spread="3"/>
                    <measurement group_id="O2" value="6" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0146</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Methadone</title>
          <description>Patients will receive 0.2 mg/kg of methadone IV immediately after intubation
Methadone: Patients will receive 0.2 mg/kg of methadone IV immediately after intubation</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>Patient will receive current standard-of-care: 0.2 mg/kg of morphine IV immediately after intubation
Morphine: Patients will receive 0.2 mg/kg of morphine IV immediately after intubation</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Nancy Alsip</name_or_title>
      <organization>University Louisville</organization>
      <phone>502-852-2905</phone>
      <email>nlalsi01@exchange.louisville.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

